Cancer news

Latest news, press releases and blog posts from Cancer Research UK.


UK scientists develop safer bone marrow transplant technique

Scientists have developed a new bone marrow transplant technique that only requires a small dose of chemotherapy and may therefore make treatment safer and less...

Possible new treatment for stomach cancer

A combination of pre and postoperative chemotherapy has been found to improve the survival rates of patients with stomach cancer over those who receive only surgery.

Chemo instead of radiotherapy cuts long-term side effects for children with brain tumours

Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term...

Drug trial success could reduce risk of bladder cancer recurring by a third

A major bladder cancer trial, funded by Cancer Research UK, has shown that adding two commonly used chemotherapy drugs to traditional radiotherapy can reduce the chance of...

Cancer Research UK scientists discover pattern of genetic faults to predict cancer drug success

A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer...

MRI drug boosts chemotherapy says study

A chemical used to enhance medical scans may also boost the potency of chemotherapy, scientists have suggested.

Potential treatment for acute myeloid leukaemia identified

Scientists from the United States have identified a protein that affects the development of acute myeloid leukaemia (AML) and found that an experimental drug blocks its...

Proof that controversial therapy is effective

Cancer Research UK scientists have for the first time shown that a controversial treatment is more effective than traditional chemotherapy for treating multiple myeloma, a...

Temozolomide sales reach $1 billion

Sales of Temozolomide*, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion**.

Cancer Research UK launches trial of experimental drug combination for advanced stomach and oesophageal cancer

Cancer Research UK’s Drug Development Office (DDO) has joined forces with academia and industry to open a clinical trial that will test an experimental drug from...